LB Pharmaceuticals

tenant

drug

Nicotine lozenge

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

small molecule

Pre-approval / investigational in the US

Developed by University of Minnesota

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

small molecule

Indications

Investigational (via trials)

Schizophrenia Bipolar Disorder I Smoking Cessation Cigarette Smoking Bipolar Disorder Cigarette Smoking Smoking Cessation Mental Disorders Schizophrenia Depressive Disorder, Major Major Depressive Disorder Mental Illness Bipolar II Disorder Psychotic Disorders Psychotic Disorders

Trials

1

Treating Smokers With Mental Illness

NCT03822416Phase 2Completed

KOLs & investigators

1

Harry Lando, PhD

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

University of Minnesota

company

trial

Treating Smokers With Mental Illness

PHASE2

trial

indication

indication

Bipolar Disorder I

indication

Smoking Cessation

indication

Cigarette Smoking

indication

KOL

Harry Lando, PhD

KOL score —

person